81
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans

, , , &
Pages 3177-3187 | Accepted 16 Oct 2007, Published online: 07 Nov 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Nicolas Vandenbussche & Peter J Goadsby. (2019) The discovery and development of inhaled therapeutics for migraine. Expert Opinion on Drug Discovery 14:6, pages 591-599.
Read now
Cláudia A Fernandes & Rita Vanbever. (2009) Preclinical models for pulmonary drug delivery. Expert Opinion on Drug Delivery 6:11, pages 1231-1245.
Read now
Stephen B. Shrewsbury, Shashidhar H. Kori, S. David Miller, Andrew Pedinoff & Steven Weinstein. (2008) Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics. Current Medical Research and Opinion 24:7, pages 1977-1985.
Read now

Articles from other publishers (15)

Preeti Dali & Pravin Shende. (2022) Inclusion complex of cyclodextrin with ergotamine and evaluation of cyclodextrin-based nanosponges. Journal of Inclusion Phenomena and Macrocyclic Chemistry 102:7-8, pages 669-682.
Crossref
Andrew R. Clark. (2022) Half a Century of Technological Advances in Pulmonary Drug Delivery: A Personal Perspective. Frontiers in Drug Delivery 2.
Crossref
Astrid Bacle, Guillaume Bouzillé, Arnaud Bruyère, Marc Cuggia, Olivier Fardel & Pascal Le Corre. (2021) Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans. European Journal of Pharmaceutics and Biopharmaceutics 164, pages 36-53.
Crossref
Abraham J. Nagy & Alan M. Rapoport. (2013) Update on future headache treatments. Neurological Sciences 34:S1, pages 101-108.
Crossref
Anthony J. Hickey. (2013) Back to the Future: Inhaled Drug Products. Journal of Pharmaceutical Sciences 102:4, pages 1165-1172.
Crossref
Andrew R. Clark. (2012) Understanding Penetration Index Measurements and Regional Lung Targeting. Journal of Aerosol Medicine and Pulmonary Drug Delivery 25:4, pages 179-187.
Crossref
Alan M. Rapoport. (2012) The therapeutic future in headache. Neurological Sciences 33:S1, pages 119-125.
Crossref
A. Rapoport. (2011) New frontiers in headache therapy. Neurological Sciences 32:S1, pages 105-109.
Crossref
David CipollaHak-Kim Chan, Jeffrey Schuster & Dino Farina. (2010) Personalizing aerosol medicine: development of delivery systems tailored to the individual. Therapeutic Delivery 1:5, pages 667-682.
Crossref
Alan M. Rapoport. (2010) New acute treatments for headache. Neurological Sciences 31:S1, pages 129-132.
Crossref
Sheena K. Aurora, Todd D. Rozen, Shashidhar H. Kori & Stephen B. Shrewsbury. (2009) A Randomized, Double Blind, Placebo-Controlled Study of MAP0004 in Adult Patients With Migraine. Headache: The Journal of Head and Face Pain 49:6, pages 826-837.
Crossref
A. Rapoport. (2009) Antimigraine drugs: new frontiers. Neurological Sciences 30:S1, pages 49-54.
Crossref
Antoine Minne, Hélène Boireau, Maria Joao Horta & Rita Vanbever. (2008) Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients. European Journal of Pharmaceutics and Biopharmaceutics 70:3, pages 839-844.
Crossref
S B Shrewsbury, M Stonerook & J K Okikawa. (2008) Intrapulmonary and intravenous administrations of dihydroergotamine mesylate have similar cardiovascular effects in the conscious dog. British Journal of Pharmacology 154:6, pages 1254-1265.
Crossref
Stephen B. Shrewsbury, Thomas A. Armer, Stephen P. Newman & Gary Pitcairn. (2008) Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate. International Journal of Pharmaceutics 356:1-2, pages 137-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.